26 November 2020
The platform that allows researchers to fully exploit available CRC studies is now available
The translation and validation of pre-clinical findings is often hampered and delayed due to unfamiliarity of basic researchers with trial cohorts providing valuable patient materials. But the new and updated CRC platform will contribute to changing that.
17 November 2020
Shedding light on viral infections
In times of a pandemic, there is not a day that goes by without news about viruses. Still, the newest paper from the lab of Oncode Investigator Marvin Tanenbaum, performed in collaboration with the group of Frank van Kuppeveld (University Utrecht), is something special.
27 October 2020
First finalized Oncode Clinical Proof of Concept (CPoC) project
We are happy to announce that our first Oncode CPoC study - a collaboration between Oncode Investigator Jean Paul Medema (Amsterdam UMC) and clinician Henk Verheul (Radboud UMC) titled Pulsatile high dose Sunitinib as a specific drug for (a subset of) metastatic mesenchymal CRCs - is now finalized.
12 October 2020
New CPoC grant awarded: researchers and clinicians team up for study on gastroenteropancreatic neuroendocrine tumors (GEPNETs)
Oncode Institute keeps investing in bringing insights from basic science into clinical practice. With the 12th grant awarded within the CPoC programme, Oncode Investigator Roland Kanaar together with Oncode researcher Julie Nonnekens (both Erasmus MC) will team up with a group of clinicians, a physicist and pharmacist for a project focused on gastroenteropancreatic neuroendocrine tumors (GEPNETs).
29 September 2020
Oncode Facilities & Technologies will add value to your research
The goal of Oncode Institute is to translate the results of ground-breaking fundamental research into the clinic faster, in order to improve the chances of cancer patients. Investing in new technologies and facilities - which are available to all Oncode researchers - is one of the ways that Oncode wants to contribute to breakthroughs in cancer research. In this interview Jacqueline Staring, Programme Manager at Oncode Institute, discusses the facilities and technologies that are available for the Oncode research community and how they will support and accelerate oncology research.
Fundamental science, clinical testing and a sharp mind for market opportunities: at Oncode we bring it all together to create impact for patients.
Scroll for more